Zenotech Laboratories (BOM:532039) Days Sales Outstanding : 36.65 (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories Days Sales Outstanding?

Zenotech Laboratories's average Accounts Receivable for the three months ended in Mar. 2024 was ₹32.5 Mil. Zenotech Laboratories's Revenue for the three months ended in Mar. 2024 was ₹80.9 Mil. Hence, Zenotech Laboratories's Days Sales Outstanding for the three months ended in Mar. 2024 was 36.65.

The historical rank and industry rank for Zenotech Laboratories's Days Sales Outstanding or its related term are showing as below:

BOM:532039' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.08 Med: 32.86 Max: 65.79
Current: 36.66

During the past 13 years, Zenotech Laboratories's highest Days Sales Outstanding was 65.79. The lowest was 0.08. And the median was 32.86.

BOM:532039's Days Sales Outstanding is ranked better than
82.73% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.42 vs BOM:532039: 36.66

Zenotech Laboratories's Days Sales Outstanding increased from Mar. 2023 (30.46) to Mar. 2024 (36.65).

Zenotech Laboratories Days Sales Outstanding Historical Data

The historical data trend for Zenotech Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenotech Laboratories Days Sales Outstanding Chart

Zenotech Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

29.66

53.32

43.42

34.51

32.63

Zenotech Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															30.46	36.81	39.11	41.42	36.65

Competitive Comparison of Zenotech Laboratories's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenotech Laboratories's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's Days Sales Outstanding falls into.

Zenotech Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Zenotech Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (33.235	+	32.494)	/	2 )	/	367.615	*	365
=	32.8645					/	367.615	*	365
=	32.63

Zenotech Laboratories's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	32.494)	/	1 )	/	80.896	*	365 / 4
=	32.494					/	80.896	*	365 / 4
=	36.65

Zenotech Laboratories (BOM:532039) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Zenotech Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenotech Laboratories (BOM:532039) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078

Website

http://www.zenotechlab.com

Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories (BOM:532039) Headlines

No Headlines